Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRC2.L Regulatory News (RC2)

  • There is currently no data for RC2

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Exercise of Convertible Loan Notes&Issue of Equity

17 Oct 2016 07:00

RNS Number : 6567M
Reconstruction Capital II Ltd
17 October 2016
 

17 October 2016

Reconstruction Capital II Limited

Exercise of Convertible Loan Notes and Issue of Equity

Reconstruction Capital II Limited ("the Company") announces that on 13 October 2016, it had received applications from holders of EUR 353,000 of convertible loan notes (each of which confers the right to receive 7.41 ordinary shares of EUR 0.01 each in the capital of the Company ("Ordinary Shares") for every EUR 1.0 face value of the convertible loan note) including, from Mr Markus Winkler, Director of the Company, a total of EUR 110,000 of convertible loan notes.

Accordingly, the Company announces that it will be issuing and allotting 2,615,730 Ordinary Shares, subject to admission to trading. Application will be made for the new Ordinary Shares to be admitted to trading on AIM. It is expected that dealings in the new Ordinary Shares will commence at 8.00 a.m. on 19 October 2016 ("Admission").

Following Admission, the Company announces that all holders of convertible loan notes have exercised their right to convert the loan notes to equity and therefore that there are no further convertible loan notes in issue.

Total Voting Rights

Following Admission the Company will have 147,622,267 Ordinary Shares in issue with voting rights. This figure of 147,622,267 represents the total voting rights in the Company and may be used by shareholders as the denominator for the calculations by which they can determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority's Disclosure and Transparency Rules.

The information contained within this announcement is considered to be inside information prior to its release as defined in Article 7 of the Market Abuse Regulation No. 596/2014 and is disclosed in accordance with the Company's obligations under Article 17 of those Regulations.

 

For further information, please contact:

Reconstruction Capital II Limited

Ion Florescu/Anca Moraru

Tel: +40 21 3167680

 

Grant Thornton UK LLP (Nominated Adviser)

Philip Secrett/Carolyn Sansom

Tel: +44 (0) 20 7383 5100

 

Panmure Gordon (UK) Limited (Broker)

Paul Fincham/Jonathan Becher

Tel: +44 (0) 20 7886 2500

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IOEMFBFTMBMBBAF
Date   Source Headline
13th Apr 20217:00 amRNSQuarterly report to 31 December 2020
26th Mar 202110:56 amRNSNew Valuations of Private Equity Positions
2nd Feb 20212:00 pmRNSLoan Arrangement
11th Nov 202010:54 amRNSQuarterly report
16th Oct 20203:17 pmRNSNet Asset Value(s)
21st Aug 20202:00 pmRNSInterim Unaudited Financial Statements
11th Aug 202012:00 pmRNSQuarterly Report
6th Aug 202011:00 amRNSLoan Facility
16th Jul 202012:36 pmRNSNet Asset Value and Quarterly Report
12th Jun 202010:51 amRNSAnnual Report and Audited Financial Statements
19th May 20209:30 amRNSQuarterly Report
27th Apr 20203:45 pmRNSNet Asset Value and Quarterly Report
9th Apr 202010:41 amRNSNAV, Quarterly Report
30th Mar 20202:30 pmRNSNew Valuations of Private Equity Positions
16th Dec 201910:40 amRNSTransaction in Own Shares
12th Dec 20191:52 pmRNSTransaction in Own Shares
15th Nov 201910:33 amRNSQuarterly Report
18th Oct 20191:09 pmRNSNet Asset Value and Quarterly Report
25th Sep 201911:44 amRNSDisposal of last plot of Policolor S.A. site
2nd Sep 201911:01 amRNSDirector Appointment
12th Aug 201911:12 amRNSInterim Unaudited Financial Statements
7th Aug 20192:49 pmRNSQuarterly report
22nd Jul 20199:33 amRNSNet Asset Value and Quarterly Report
14th Jun 20191:20 pmRNSAnnual Report and Audited Financial Statements
28th May 20195:58 pmRNSQuarterly report
3rd Apr 20193:19 pmRNSNew Valuations of Private Equity Positions
23rd Jan 20195:23 pmRNSTransaction in Own Shares
23rd Jan 201912:31 pmRNSTransaction in Own Shares
21st Dec 20185:27 pmRNSTransaction in Own Shares, Purchase of RIF Shares
18th Dec 20185:08 pmRNSDirector Resignation
16th Nov 20184:27 pmRNSTransaction in Own Shares and Total Voting Rights
2nd Nov 201811:34 amRNSQuarterly Report
22nd Oct 20189:05 amRNSNet Asset Value and Quarterly Report
20th Aug 20189:16 amRNSInterim Unaudited Financial Statements
14th Aug 20183:41 pmRNSQuarterly Report
3rd Aug 20181:24 pmRNSNet Asset Value and Quarterly Report
19th Jul 20183:03 pmRNSTransaction in Own Shares and Total Voting Rights
13th Jul 201812:25 pmRNSTransaction in Own Shares and Total Voting Rights
9th Jul 201810:37 amRNSHolding(s) in Company
20th Jun 20185:32 pmRNSAnnual Report and Audited Financial Statements
10th May 20183:11 pmRNSNet Asset Value and Quarterly Report
14th Mar 20187:00 amRNSNAV, Quarterly Report and New PE Valuations
21st Feb 20182:51 pmRNSResult of AGM
26th Jan 201812:00 pmRNSPublication of Circular
12th Jan 20181:33 pmRNSProposed acquisition & change of investing policy
19th Dec 20174:37 pmRNSNet Asset Value and Monthly Report
29th Nov 20174:38 pmRNSNet Asset Value and Monthly Report
20th Nov 20177:00 amRNSChange of Adviser
13th Nov 201711:02 amRNSQuarterly Report
31st Oct 20174:33 pmRNSNet Asset Value and Quarterly Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.